Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -1.25% | +5.33% | +293.03% |
Evolution of the average Target Price on Perspective Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Perspective Therapeutics, Inc.
B. Riley | |
Oppenheimer | |
JonesTrading Institutional Services | |
Northland Securities |
EPS Revisions
- Stock Market
- Equities
- CATX Stock
- Consensus Perspective Therapeutics, Inc.